Trial Profile
Acute and sub-acute effect of ferric carboxymaltose on inflammation and adhesion molecules in patients with predialysis chronic renal failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- 17 Dec 2015 New trial record